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Effects of naturally-occurring acid fog on
inflammatory mediators in airway and pulmonary
functions in asthmatic patients
S. HONMA*, H. TANAKA*, S. TERAMOTO*, T. IGARASHI{ AND S. ABE*
*Third Department of Internal Medicine, Sapporo Medical University School of Medicine, Sapporo and
{Respiratory Medicine, Kushiro City General Hospital, Kushiro, Japan
Floating fog occurs every summer in Kushiro City in Japan, and the annual average of fog water pH in the past 4
years has been under 5?0. We previously reported that epidemiologically fog was the most important positive factor
contributing to increased hospital visits of asthmatic patients compared with other meteorological values and air
pollutants. This study aimed to investigate the mechanism of the effects of naturally-occurring acid fog on
asthmatic patients. We compared pulmonary functions and inflammatory mediators in induced sputum between
the foggy (July 1995) and the non-foggy (May 1996) season, and assessed airway responsiveness to hypo-osmolar
aerosol. Forty-four out of 118 asthmatic patients of Kushiro City residents participated, pulmonary function tests
were completed in 36 patients, and sputum data were available in 26 patients in both seasons.
Percent forced expiratory volume in 1 sec (FEV1) was significantly (P50?05) decreased, and % peak expiratory
flow rate (PEFR) had a trend to decrease in the foggy season more than in the non-foggy, and sputum eosinophil
cationic protein (ECP) and interleukin (IL)-8 were higher in the foggy season but not significantly. A moderate
inverse correlation was revealed between sputum ECP and %PEFR in the foggy season (r=70?55, P50?005).
Subjects were divided into two groups according to the best PEFR; one had410% lower PEFR levels in the foggy
season than in the non-foggy season (Group A, n=7), the remainder did not (Group B, n=19). In group A, sputum
ECP was significantly increased (P50?01) in the foggy season, but there were no changes in IL-8 and prostaglandin
D2. Ultrasonic nebulized distilled water provocation test revealed no differences between group A and B.
These results suggested that eosinophilic inflammation rather than hypo-osmolar effect of fog might contribute to
respiratory deterioration by inhalation of naturally-occurring acid fog.
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Naturally-occurring fog has recently been shown to be
quite acidic (1,2). In Kushiro, a city with only a small
industrial area located in northeastern Japan, where
floating fog from the Pacific Ocean frequently occurs every
summer, the average fog pH from 1992 to 1995 was under
5?0 and the minimum was 2?8. We recently reported that
asthma hospital visits increased by 8?8% on fog days (3),
and epidemiologically fog was the most important positive
factor contributing to an increase in visits compared with
other meteorological values and air pollutants (4) in aReceived 8 July 1999 and accepted in revised form 22 February
2000.
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disasters with high mortality and morbidity rates have
occurred during periods of fog. For example, during the
December 1952 London fog, a classic example of a major
air pollution episode, increases were seen in both daily
mortality and hospital admission (5). In The Harvard Six
Cities Study, chronic coughs and bronchitis were more
closely correlated with hydrogen ion (H+) concentration
than with particle concentration (6). Daily ambient
concentrations of H+ in Denver were associated with
cough and shortness of breath in a large panel of adult
asthmatic patients (7). Koenig et al. (8) reported that acidic
pollutants increased airway resistance in asthmatics. On the
other hand, exposure to sulphuric acid aerosol had no
change in pulmonary function between before and after
inhalation (9,10). Leduc et al. (2) reported no significant
changes of pulmonary functions and airway hyper-respon-
siveness by short-term inhalation of artificially made# 2000 HARCOURT PUBLISHERS LTD
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fog, but a tendency of worsening was observed.
The natural occurrence of excessive acid aerosol and
particulates were associated with declines in peak expira-
tory flow rates (PEFRs) in children (11). Adverse changes
in PEFR occurred at a pollution level below current WHO
guide levels in patients with obstructive airway disease (12).
Recently, Raizenne et al. (13) reported that long-term
exposure to ambient particle strong acidity may have a
deleterious effect on lung growth and function in children.
Although many epidemiological and experimental studies
have been performed, there are no reports detailing a direct
comparison of inflammatory mediators in airway between
foggy and non-foggy days.
In this study, in order to elucidate the mechanism of the
influence of naturally-occurring acid fog on airway
inflammation in asthmatic patients, we investigated pul-
monary functions and inflammatory mediators in hyper-
tonic saline induced sputum and compared them
respectively between the foggy and non-foggy season. To
investigate the effect of hypo-osmolar aerosol, we assessed
airway responsiveness to ultrasonic nebulized distilled
water (UNDW) inhalation.
Materials and methods
SUBJECTS
All asthmatic patients were recruited from Kushiro City
General Hospital. The diagnosis of asthma was defined as a
history of recurrent episodes of wheezing and chest
tightness with ongoing reversible airway obstruction
(20% variability in FEV1 on a week to week basis or at
least 15% improvement in FEV1 post bronchodilator).
Atopy was defined by one or more positive specific serum
IgE tested by a commercial kit (MAST systems1, Hitachi
Kasei, Tokyo, Japan). The MAST system includes 16
antigens (house dust, Dermatophagoides pteronyssinus,
Dermatophagoides farinae, ragweed, orchard grass and
two other grasses, Japanese cedar, Alternaria, another four
moulds and cat, dog, egg and soya bean).
Of the 257 asthmatic patients who visited Kushiro City
General Hospital in 1995, 182 subjects were Kushiro City
residents. Before this study we gave a questionnaire to 120
patients resident in Kushiro City at the outpatient division
of the hospital, and it was returned by 118 of them (mean
age 53, ranged from 20–79 years; 69 women and 49 men).
This self-administered questionnaire asked questions about
the relationship between asthma symptoms and fog
occurrence, requiring answers of yes (positive correlation),
no (no connection), or unknown. Out of 118 patients who
were residents in Kushiro City, 44 volunteer patients
participated in this study after giving informed consent.
STUDY DESIGN
We performed (i) pulmonary function tests and hypertonic
saline induced sputum collection on both foggy days (24–28
July 1995) and non-foggy days (20–23 May 1996), (ii)airways responsiveness to UNDW provocation test on non-
foggy days.
The pulmonary functions were measured by a standard
spirometer (Chestac 25, Chest, Tokyo, Japan). These
measurements both on foggy and non-foggy season were
performed at approximately the same time, between 09:00 h
and 13:00 h, and on same day of the week because of
elimination of the influence of circadian variation of lung
function. The pulmonary function tests were repeated three
times, and the data having the best PEFR value were
obtained. Nebulized hypertonic saline induced sputum was
performed after the pulmonary function tests. The method
of induction procedure described by Pin et al. (14) was
followed but was made safer by beginning with an aerosol
of normal saline followed by 3% saline solution generated
by an ultrasonic nebulizer (NE-U10B, OMRON, Tokyo,
Japan) with an output of 1mlmin71 and particle size of
4?5 mm aerodynamic mass median diameter. The aerosol
was inhaled for 1 or 2min according to the severity of
airflow obstruction, and FEV1 was measured. Patients were
asked to rinse the mouth, swallow the water and blow the
nose to minimize contamination with saliva and post-nasal
drip. They were instructed to cough sputum into a sterile
plastic container whenever they felt that sputum might be
present. These procedures were repeated for up to a total of
15min of inhalation until a sputum sample was obtained or
a fall in the FEV1^10% occurred. The volumes of the
sputum samples were determined, and a four-fold volume
of saline was added. The samples were then mixed gently by
touch mixer (MT311, Yamato Scientific, Tokyo, Japan) for
2min. The homogenized sputum samples were centrifuged
at 2000 rpm for 15min. The supernatants were aspirated
and frozen at 7808C for later analysis.
Airway responsiveness to methacholine was measured as
baseline pulmonary function with Astograph (TCK-
6000CV1, Chest, Tokyo, Japan) developed by Takishima
et al. (15). Briefly, methacholine aerosol was continuously
inhaled through the mouth by tidal breathing for 1min in
series between 0?049–100mgml71 where concentrations
were doubled each time. The aerosol was generated by a
micronebulizer with an output of 0?15mlmin71, and the
size of particles ranged from 0?5 to 4?0mm. Bronchial
responsiveness was measured from the change in respira-
tory resistance (Rrs, cm H2O 1
71 sec71) obtained by the
3Hz forced oscillation technique. Rrs was continuously and
simultaneously measured during inhalation of the aerosols.
When Rrs reached twice the initial level a bronchodilator
aerosol (2% salbutamol) was inhaled for 4min. We did not
perform this procedure if the patients had initial Rrs more
than 8 cmH2O 1
71sec71. The cumulative methacholine
dose required to reduce respiratory conductance (Grs=1
Rrs71, 1 sec71 cmH2O
71) by 35% of the baseline value
(PD35Grs) was determined. PD35 Grs was calculated in
terms of a unit (U) defined as 1min inhalation of 1mgml71
methacholine.
UNDW provocation test was performed according to the
modified method described by Groot et al. (16,17). The
bronchoconstrictive responses to UNDW provocation were
assessed by FEV1. Baseline FEV1 was recorded from the
best of these reproducible values (within 5%). An ultrasonic
ACID FOG AND ASTHMA 937nebulizer (NE-U10B, OMRON, Tokyo, Japan) was used at
a fixed output of 1mlmin71. The patient inhaled UNDW
during tidal breathing through a mouthpiece with tightened
lips. Subjects inhaled for 30 sec, 1min, 2min and 4min. The
test was stopped if FEV1 dropped more than 20% from the
baseline value. The cumulative dose of inhaled distilled
water in ml H2O causing a 20% fall in FEV1 from post-air
values (PD20, UNDW), was calculated by linear interpolation
on a semilogarithmic curve.
ASSAY FOR ECP, IL-8 AND PGD2
Eosinophil cationic protein (ECP) in sputum was deter-
mined by means of specific and sensitive double-antibody
radio-immunoassay by a Pharmacia ECP RIA kit (Phar-
macia Diagnostica, Uppsala, Sweden). Reproducibility of
the assay was good; coecient of variations of inner assay
and inter assay were 8?9% and 7?5%. The detection limit of
the assay was 52 mg l71.
An ELISA kit for human IL-8 (Toray-Fuji Bionics,
Tokyo, Japan) was used to measure IL-8 titre in sputum.
This assay used the quantitative immunometric sandwich
ELISA technique. This ELISA kit consistently detects IL-8
levels above 12?5 pgml71; it does not detect other cytokines
such as interferons, IL-2, IL-6 and GM-CSF. Reproduci-
bility of the assay was as follows; coecient of variations of
inner assay and inter assay were 3?8% and 5?8%.
Indomethacin was added to the rest of the sputum
samples and stored at 7308C. Octadecylsilyl silica (ODS)
powder suspension 1ml (80mg ODSml71 40% ethanol)
was added to each 1ml of sputum sample under acidic
condition, to absorb PGs. Then, ethanol-acid solution
(15% ethanol with 0?05N HCl) and petroleum ether were
added for washing. Deproteinization and defatting were
performed and PGs were eluted by ethyl acetate. Eluted
PGs were applied to a Si minicolumn Bond Elut Si (Varian,
Harbor City, CA, U.S.A.) and consequently fractionated
by the eluent 1 (Chloroform: acetic acid=100:0?5), eluent 2
(acetonitrile: chloroform: acetic acid=10:90:0?5), and
eluent 3 (aceonitrile: chloroform: acetic acid=20:80:0?5).
The fraction obtained by fraction 3 was evaporated by N2
gas and reconstructed by the buffer of the commercial kit of
a Prostaglandin D2 [
3H] assay system (Amersham, Buck-
inghamshire, U.K.), and PGD2 was measured using this kit.
Reproducibility of the assay was as follows; coecient of
variations of inner assay and inter assay were 13?6% and
10?8%.
FOG ASSESSMENT
The method of fog water collection has previously reported
(18). Briefly, fog water was sampled using a screen
collector, and droplets were collected by inertial impaction
on an angled screen made of polyamide strands. Droplets
coalesce rapidly on these strands and flow downward due to
gravity and aerodynamically drain into a funnel, which
drains the fog water into a preweighted polyethylene
collection bottle. In this study, six fogwater samples
corresponding to four fog events were taken between24 July 1995 and 28 July 1995. As soon as possible after
collection, samples were filtered through 0?45 mm pore
membrane filters to prevent any change in the concentra-
tions of the chemical species. The conductivity and the pH
were measured immediately after sample filtration. The
fogwaters were stored at 7808C until analysis. SO4
27,
NO3
7, and Cl7 were measured by ion chromatography,
and NH4
+ analysed by visual colorimetry on an auto
analyzer. Na+ K+, Ca2+ and Mg2+ were determined by
atomic absorption spectrophotometry.
STATISTICAL ANALYSIS
All data were expressed as means +SEM (standard error of
the mean). Patients’ characteristics were analysed with the
w2 and un-paired t-tests. We used the paired t-test to
compare PEFR, %PEFR, FEV1, %FEV1, Rrs,
PD20,UNDW, ECP, IL-8 and PGD2 between the foggy and
non-foggy seasons. Mann-Whitney U-test was used in
comparisons between group A and B. Pearson correlations
were calculated from % predicted PEFR and sputum ECP
and Fisher’s r to z was used to calculate P-values for the
correlations. The level of critical significance was assigned
at P50?05.
Results
In the self-administered questionnaire, 39 out of 118
patients (33?0%) reported exacerbation of asthma on foggy
days, 23 patients (19?5%) reported no exacerbation on
foggy days and 56 patients (47?5%) could not decide
whether exacerbation had occurred or not on foggy days.
Out of 44 volunteer patients who participated in this study,
15 were ‘yes’ sayers, 12 were ‘no’ sayers and the remaining
17 could not decide whether exacerbation had occurred or
not on foggy days.
In July 1995, fog appeared on 23 days, and during this
study (21–24 July 1995) fog occurred on 4 days. It was
possible to measure the fogwater composition in three out
of six samples. The pH of the three samples was 3?0, 3?0
and 3?2, respectively. The average composition of the
fogwater shown in Fig. 1, was dominated by NH4
+ and
SO4
27 and to a lesser extent by NO3
7 and Cl7. Each mean
concentration and the range was as follows: 3?88m Eq l71
(2?08–6?45) for SO4
27, 2?56mEq l71 (1?24–3?54) for
NO3
7, 1?08mEq l71 (0?19–2?45) for Cl71, 5?47mEq l71
(2?37–9?27) for NH4
+, 0?92mEq l71 (0?52–1?73) for Na+,
0?76mEq l71 (0?64–1?0) for H+, and 0?24mEq l71 (0?13–
0?32) for the remaining cations.
Of 44 patients, 36 were able to perform the complete
study. Four patients were excluded because they could not
performed the second examination and four subjects were
excluded because of upper respiratory tract infection during
this study. Twenty-six out of 36 patients could obtain
sputum samples completely.
In 36 patients, there was a significant difference in
%FEV1 and a tendency to decrease in %PEFR between the
foggy and non-foggy season (Table 1). Sputum ECP and
FIG. 1. Average composition (%) of fogwater during this
study.
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compared with those in the non-foggy season (Table 2).
As shown in Table 3, the 26 patients were further divided
into two groups according to PEFR; one had410% lower
PEFR levels in the foggy season than in the non-foggy
season (Group A, n=7), the remainder did not (Group B,
n=19). There was no significant difference between Group
A and B in age, sex, atopic status, smoking and baseline %
predicted FEV1 and PD35Grs. All 26 patients are Kushiro
City residents and there were no significant difference in
residing years between group A and B (47+5 years vs.
35+4). In group A, ECP values were significantly higher in
the foggy season than non-foggy season, but not in group B
(Table 4). In sputum PGD2 and IL-8 levels, there were noTABLE 1. Lung functions in the foggy and non-foggy season
%peak expiratory flow rate (%)
%forced expiratory volume in one second (%)
Respirtory resistance (cmH2O l
71 sec71)
mean+SE
TABLE 2. Sputum mediators in the foggy and non-foggy season
Fog
Eosinophil cationic protein (mgml71) 400+
Interleukin-8 (pgml71) 1886+
Prostaglandin D2 (mgml
71) 53+
mean+SEsignificant differences in any of the group A and B individuals
between the foggy and non-foggy season (Table 4).
In the foggy season there was a moderately inverse
correlation between sputum ECP levels and % predicted
PEFR (r=0?55, P=0?004), but not in PEFR, FEV1, %
predicted FEV1 and Rrs (Fig. 2).
UNDW inhalation test did not show any significant
difference in PD20,UNDW between group A and group B
(2?6+0?1ml vs. 2?5+0?3).
Discussion
Our study is the first report to investigate pulmonary
functions and inflammatory mediators in induced sputum
in the setting of naturally-occurring acid fog. We found that
naturally-occurring acid fog had unfavourable respiratory
effects on the subgroup in asthmatic patients, and
eosinophil-mediated airway inflammation might contribute
to this mechanism. Since the decrease in FEV1 of the
patients caused by hypo-osmolar aerosol did not differ
from that of the remainder, air pollutants dissolved in
fogwater might be one of the sources responsible for the
problem. Many air pollutants, i.e. nitrogen dioxide (NO2)
and sulphur dioxide (SO2), are absorbed in fogwater, and
this may increase the acidity of fogwater. High concentra-
tion of H2SO4 aerosol have failed to cause normal subjects
to develop significant decrease in pulmonary functions, but
subjects with asthma are more sensitive to the effects of this
pollutant (19–21). Studies of NO2 exposure have demon-
strated inconsistent effects on lung function (22). Recently,
an ambient level of NO2 (0?26 ppm) caused a delayed effect
on bronchial responsiveness in asthmatic patients (23).
Although SO2 and NO2 alone do not appear to have a
priming effect in the airway inflammation of asthmatic
patients, exposure to a mixture of 0?2 ppm SO4 and 0?4 ppm
NO2 for 6 h enhanced sensitivity of mild asthmatic patients
to inhaled antigen (24). Naturally-occurring acid fogFoggy Non-foggy P-value
64?1+3?7 75?9+5?3 0?05
62?4+3?5 68?7+2?9 0?04
6?2+0?7 5?7+0?4 0?37
gy Non-foggy P-value
95 273+67 0?1
509 478+241 0?08
9 46+15 0?8
TABLE 3. Characteristics of 26 patients
Group Case Age Sex Atopy Smoking
(pack-years)
Baseline FEV1
(%pred.)
PD35Grs
(U)
PEFR Treatment
Foggy
season
(lmin71)
Non-foggy
season (lmin71)
A 1 51 F no 0 58?1 n.d. 147 240 B
2 67 F no 41?3 71?1 8?7 99 123 T
3 75 M no 54 58 1?8 274 336 T
4 62 F yes 0 78?4 12?5 138 269 B
5 67 M no 32 38?3 0?02 173 218 T, B
6 67 F yes 0 66?6 n.d. 138 198 T, B
7 53 F yes 0 75?4 n.d. 189 264 T, B, S
B 8 69 F no 0 67?5 1?3 203 215 T, B
9 34 F yes 2?5 67?5 n.d. 241 252 T, B
10 61 F yes 0 90?3 n.d. 268 295 T, B
11 70 M no 3?5 95?3 n.d. 589 597 T
12 68 M no 16?5 56 n.d. 300 251 T, B
13 36 F yes 0 68?4 n.d. 233 149 T, B
14 57 M yes 32 36?3 n.d. 324 297 S
15 60 F yes 0 46?6 0?3 233 205 T, B
16 54 F yes 0 32?6 4?6 345 303 T, B
17 62 F no 0 80 0?9 338 281 T
18 68 M no 0 103?6 4?6 432 439 B
19 31 M yes 0 107?4 n.d. 610 569 T
20 72 F yes 0 86?2 7?5 408 415 T
21 55 F yes 0 63?6 6?8 560 520 B
22 66 F yes 41 70?2 4?0 310 300 B
23 48 F yes 0 48?8 0?08 229 207 T
24 62 F no 0 77?4 0?2 225 234 T
25 45 F no 0 96?6 12?5 304 352 T
26 61 F yes 0 67?6 1?4 440 465 T, B
FEV1: Forced expiratory volume in 1 sec; PD35Grs: cumulating dose of methacholine causing a decrease of 35% in respiratory
conductance; PEFR: peak expiratory flow rate; T: thephylline; B: inhaled b2-agonist; S: inhaled beclomethasone dipropionate:
n.d.: not done.
TABLE 4. Comparisons of sputum mediators between the foggy and non-foggy season in group A and B
Group Foggy Non-foggy P*-value
Eosinophil cationic protein (mgml71) A 591+170 306+120 0?007
B 292+86 246+77 0?9
P**-value 0?1 0?7
Interleukin-8 (pgml71) A 2322+1021 959+731 0?4
B 1485+516 208+104 0?1
P**-value 0?5 0?1
Prostaglandin D2 (mgml
71) A 37+18 36+22 0?1
B 62+15 46+24 0?3
P**-value 0?6 0?7
P*: foggy season vs. non-foggy season;
P**: group A vs. group B.
mean+SE
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FIG. 2. Relationship between sputum ECP and %
predicted PEFR values of all 24 patients.
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inhalation of the acid aerosol might be more harmful than
SO2 and NO2 alone.
The ionic composition and the relative ratios of the ions
in the acid fogwater in this study were similar to the
previous results (2,25), i.e. the dominant components were
SO4
27, NO3
7 and NH4
+. Larson et al. (26) calculated that
endogeneous ammonia (NH3) in upper airways should
neutralize inhaled gaseous strong acids inside the airways,
or outside in the breathing zone. In this study, we could not
measure the endogeneous ammonia. However, Clark et al.
(27) reported that endogeneous ammonia did not effectively
prevent the inhalation of ambient acid, but might neutralize
roughly one-fourth of inhalable acid in healthy volunteers.
The airway epithelial cells have potency for production
of many inflammatory cytokines and adhesion molecules
including IL-1b, IL-8, IL-16, granulocyte-macrophage
colony stimulating factor (GM-CSF), regulated on activa-
tion, normal T cells expressed and secreted (RANTES) and
intercellular adhesion moelcule-1 (ICAM-1), which influ-
ences the activity of eosinophils and lymphocytes (28).
Ozone, NO2, SO2 and diesel exhaust lead to epithelial
dysfunction and/or damage and induce an acute inflamma-
tory response in the upper and lower airways (29,30). In this
study sputum IL-8 levels showed a not significant increase
in the foggy season, this might be a result of the influence of
acid fog on bronchial epithelial cells. On the other hand, it
is reported that sputum eosinophils and sputum ECP levels
are strongly correlated (31). Increased ECP levels in sputum
might be explained that the release of chemokine (i.e.
RANTES) and ICAM-1 may orchestrate the detrimental
functions of eosinophil, consequently releasing eosinophil
specific proteins such as ECP. Acute exposure to 0?4 ppm
NO2 for 6 h may ‘prime’ eosinophils for subsequent
activation by allergen in patients with allergic rhinitis
(30). In our study this eosinophil-induced airway inflam-
mation might be one of the main pathways, because %predicted PEFR was inversely correlated with only ECP
levels, not with IL-8 or PGD2 values.
In this study, the effects of inhaled glucocorticoids were
minimum. The influence of inhaled BDP on the release of
IL-8 and RANTES from nasal epithelial cells both in and
outside the pollen season following exposure to ozone was a
dose dependent inhibition (32). As inhaled steroids might
neutralize the true influence of ambient acid aerosol in the
airways, the patients of this study seemed to be suitable
subjects for detecting the true effects of acid fog.
The limitation of this study was the selection of the
patients. We could not select controlled patients and all
participants were volunteers, then we could not evaluate the
influence of the disease severity. The precise effects of acid
fog on asthmatic airways should be evaluated in patients
without any of the treatments. Comparisons of patients
baseline characteristics between the studied 26 patients and
the not studied 18 patients revealed no differences in age,
sex atopic status and baseline pulmonary functions (data
not shown), but only the use of inhaled corticosteroid was
different. Thus the patients selection of 26 from 44 patients
did not seem to be slanted.
Pulmonary functions and sputum inflammatory media-
tors were worsened in seven patients of group A in this
study, who may constitute an acid-fog susceptible sub-
group. Actually, only one out of these seven patients
answered ‘no’ in the questionnaire as to whether respiratory
symptoms are increased on foggy days. Linn et al. (33)
reported that 90-min exposure to near-ambient concentra-
tions of respirable H2SO4 aerosol did not change the mean
level of lung function in a group of 24 asthmatic volunteers.
However two of the group’s subjects showed unfavourable
function change during exposure, suggesting that chance
occurrences might be responsible, or that within the
asthmatic subjects an acid-pollution-susceptible subgroup
exists. Leduc et al. (2) reported no significant changes of
pulmonary functions and airway hyper-responsiveness by
short-term inhalation of the artificially made acid aerosol
mimicking components of naturally-occurring acid fog, but
a tendency of worsening was observed. Our preliminary
reports show that 8?8% of 102 asthmatic patients had
increased hospital visits for asthma symptoms on fog days
in Kushiro City (3). These reports agree with our results in
this study; although there were no significant changes of
pulmonary function in all asthmatic patients, an acid-fog-
sensitive subgroup might exist. Exposures in many previous
studies were single and for a short time, but in our study,
naturally-occurring acid fog was almost a daily phenom-
enon in the foggy season. A multiple exposure study to
assess the chronic influence of acid fog seemed to be needed.
Inhaltion of hypo-osmolar aerosols is a well-established
stimulus to bronchoconstriction (34), and the osmolarity of
the naturally-occurring fog was lower than 30mOsm (7).
Therefore, the hypo-osmolarity of naturally-occurring fog
could theoretically enhance the effects of acidity on the
airways. The UNDW provocation test has been used for
assessment of bronchial hyper-responsiveness (34). The
underlying mechanism of UNDW-induced bronchocon-
striction has not been clearly elucidated. Since pre-inhala-
tion of sodium cromoglycate and nedocromil sodium, as
ACID FOG AND ASTHMA 941well as atropin, can inhibit this constriction, mast cell
derived mediators and the cholinergic nerve system are
probably involved (35,36). Wang et al. (30) reported that in
nasal inflammation of asthmatic patients, exposure to
0?4 ppm NO2 for 6 h did not induce mast cell degranulation.
Such exposure also did not enhance mast cell degranulation
immediately following allergen challenge. In our data, there
were no significant differences in the degree of UNDW-
induced bronchoconstriction in non-foggy season, and
sputum PGD2 levels between group A and B in either the
foggy or non-foggy seasons. Therefore, it was suggested that
the difference in sensitivity to hypo-osmolar aerosol might
not have contributed directly to the influence of naturally-
occurring acid fog in this study.
In conclusion, naturally-occurring acid fog had
unfavourable respiratory effects on selected adult
asthmatic patients. Eosinophilic inflammation rather than
hypo-osmolar effect on airways might contribute to
respiratory deterioration by inhalation of naturally-occur-
ring acid fog.
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